Business Context and Reporting Period
This Form 8-K was filed by Second Sight Medical Products, Inc. on February 22, 2016. The report addresses a significant regulatory development regarding Medicare coverage for the company's Argus II retinal prosthesis system in specific U.S. jurisdictions.
Key Financial Metrics
The filing text does not provide specific financial data, including revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on a regulatory event under Item 8.01 (Other Events).
Material Changes
First Coast Service Options, Inc. (FCSO), the Medicare Administrative Contractor (MAC) for Jurisdiction N (covering Florida, Puerto Rico, and the U.S. Virgin Islands), removed CPT code 0100T from its list of Noncovered Services. This change enables Medicare coverage for the Argus II implantation procedure in these regions, provided the procedure meets medically reasonable and necessary thresholds.
Outlook, Commentary, and Risks
- Current Coverage Status: Five Medicare jurisdictions currently provide coverage for the Argus II when medically necessary: CGS (Ohio, Kentucky), Palmetto GBA (Virginia, West Virginia, North Carolina, South Carolina), NGS (Minnesota, Illinois, Wisconsin), NGS (Connecticut, New York, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont), and now FCSO (Florida, Puerto Rico, U.S. Virgin Islands).
- Management Commentary: The company continues to work with other MACs and payers to secure additional positive coverage policies.
- Risks/Contingencies: Coverage is contingent upon meeting all regulatory requirements, specifically the "medically reasonable and necessary" threshold. There is no national coverage policy, as determinations are delegated to regional MACs.
Investor Verification Checklist
- Verify the specific clinical criteria required to meet the "medically reasonable and necessary" threshold in Florida, Puerto Rico, and the U.S. Virgin Islands.
- Confirm the total number of Medicare jurisdictions currently covering the Argus II versus those still pending.
- Review the company's ongoing efforts and timeline for securing coverage in the remaining seven Medicare jurisdictions.
- Check for any subsequent filings regarding reimbursement rates or claim denial rates in the newly covered regions.